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Abstract
Background: Aggregatibacter actinomycetemcomitans is the etiological agent of periodontitis, and there is a strong
association between clone JP2 and aggressive periodontitis in adolescents of African descent. The JP2 clone has an
approximately 530-bp deletion (Δ530) in the promoter region of the lkt/ltx gene, which encodes leukotoxin, and
this clone has high leukotoxic activity. Therefore, this clone is very important in aggressive periodontitis. To
diagnose this disease, culture methods and conventional PCR techniques are used. However, quantitative detection
based on qPCR for the JP2 clone has not been developed due to genetic difficulties. In this study, we developed a
qPCR-based quantification method specific to the JP2 clone.
Methods: Based on our analysis of the DNA sequence of the lkt/ltx gene and its flanking region, we designed a
reverse primer specific for the Δ530 deletion border sequence and developed a JP2-specific PCR-based
quantification method using this primer. We also analyzed the DNA sequence of the Δ530 locus and found it to be
highly conserved (97–100%) among 17 non-JP2 strains. Using the Δ530 locus, we designed a qPCR primer–probe
set specific to non-JP2 clones. Next, we determined the numbers of JP2 and non-JP2 clone cells in the periodontal
pockets of patients with aggressive periodontitis.
Results: The JP2-specific primers specifically amplified the genomic DNA of the A. actinomycetemcomitans JP2
clone and did not react with other bacterial DNA, whereas the non-JP2 specific primers reacted only with A.
actinomycetemcomitans non-JP2 clones. Samples from the 88 periodontal sites in the 11 patients with aggressive
periodontitis were analyzed. The bacterial cell numbers in 88 periodontal sites ranged from 0 to 4.8 × 108 (mean
1.28 × 107) for JP2 clones and from 0 to 1.6 × 106 for non-JP2 clones (mean 1.84 × 105). There were significant
differences in the JP2 cell number between a clinical attachment level (CAL) ≤6 mm and a level ≥7 mm (p < 0.01).
Our new qPCR-based JP2- and non-JP2-specific quantitative detection assay is applicable to the diagnosis of
aggressive periodontitis with A. actinomycetemcomitans.
Conclusions: We successfully developed a quantitative and discriminative PCR-based method for the detection of
A. actinomycetemcomitans JP2 and non-JP2 clones. This technique will contribute to future analyses of the
quantitative relationship between this organism and aggressive periodontitis.
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Background
Periodontitis is an infectious disease comprising a com-
plex group of inflammatory conditions that eventually re-
sult in the loss of the teeth-supporting tissues [1]. Several
systemic diseases are thought to be associated with peri-
odontal disease [2-4]. Of the various forms of periodon-
titis, aggressive periodontitis is characterized by an early
age of onset, with molar and incisor teeth the first ones
affected in localized forms [5-7]. Studies have revealed an
association between this disease and the presence of
Aggregatibacter actinomycetemcomitans, a Gram-negative,
facultative anaerobic coccobacillus [8-10]. A. actinomyce-
temcomitans isolated from aggressive periodontitis in ado-
lescents of African descent living in different parts of the
world are genetically homogeneous and belong to a single
clone called JP2 [11-15]. The high pathogenicity of this
clone has been supported by various epidemiological stud-
ies of people of African descent [8,16]. The pathogenicity
of this clone is characterized by increased leukotoxin pro-
duction. The highly leukotoxic JP2 clone of A. actinomyce-
temcomitans serotype b is characterized by a 530-bp
deletion (Δ530) in the promoter region of the lkt/ltx gene
operon, which encodes the leukotoxin, resulting in
increased leukotoxin production [17-20]. This clone shows
pronounced racial tropism, as it has been isolated almost
exclusively from adolescent periodontitis patients of West
and Northwest African descent [14,18]. Haubek et al.
reported that the JP2 clone is an important etiological
agent in the initiation of periodontal attachment loss in
adolescents [8,21,22].
Consequently, the accurate diagnosis of this disease is
based on detecting the JP2 clone from periodontal
lesions in patients with aggressive periodontitis. Previ-
ously, subgingival plaque cultures were used to analyze
the association between the presence of the JP2 clone
and aggressive periodontitis [23]. Since this is time con-
suming, detection using cultures is not suitable for rapid
diagnosis. Molecular genetics techniques, which are rela-
tively rapid, including conventional PCR and other
molecular-based techniques, have been used to detect
the JP2 clone from subgingival plaque [24,25]. However,
these are qualitative methods, and no completely quanti-
tative molecular-based detection technique for the JP2
clone has been reported [26]. Furthermore, a quantita-
tive analysis of the A. actinomycetemcomitans JP2 clone
and the severity of aggressive periodontitis has not been
done, although positive relationships between the num-
bers of Porphyromonas gingivalis and Treponema denti-
cola cells and the severity of adult periodontitis have
been reported [27-29].
In this study, we developed a quantitative, discrimina-
tive detection method specific to A. actinomycetemcomi-
tans JP2 and non-JP2 clones using qPCR (real-time
PCR). This is the first report of quantitative detection
specific to the A. actinomycetemcomitans JP2 and non-
JP2 clones. Additionally, the relationship between the
number of cells and the severity of this disease was
examined. This method should contribute to clarifying
the quantitative relationship between the JP2 clone and
aggressive periodontitis.
Results
Analysis of the A. actinomycetemcomitans lktC locus for
primer design
Figure 1 shows the gene cluster and nucleotide sequence
of the region upstream from the ltxC/lktC locus. Down-
stream from the glyA gene, IGR1851 (IGR: non-coding re-
gion of genomic DNA, Gene ID: AA02808) was identified.
The nucleotide sequence of IGR1851 of HK1651 is on the
strand opposite that of Y4 and JP2 (Figure 1A). In the Y4
strain, the region upstream from ltxC/lktC contains a 762-
bp open-reading frame (ORF). The ORF of the JP2 clone,
named orfX', contains an approximately 530-bp deletion
compared with orfX of the non-JP2 strain. The 31-bp of
sequence at the 3’ end following the deletion is common
to both orfX and orfX’ (Figure 1B, double underlined).
Therefore, we designed an antisense primer specific to the
JP2 clone at the border of the 3' region of orfX' and this
31-bp 3' locus of orfX (Figure 1B).
Sequencing analysis of the Δ530 region for designing
non-JP2 specific primers
To evaluate the specificity of the Δ530 locus in the primer
design, we analyzed the PCR products using primer pairs
designed outside the Δ530 locus. Initially, we performed
PCR analysis using the primer pair Aa orfX3'F1 and Aa
lktC5'R1 (Figure 1A, Table 1). Of the 18 non-JP2 strains,
seven were positive using this primer set (723 bp, Table 2).
To amplify the Δ530 locus of the other strains, primer
pair Aa orfX3'F2 and Aa lktC5'R2 was also designed
(Figure 1A, Table 1). Using these primers, in 10 of 11 non-
JP2 strains, except for NCTC 9710, the locus 3’ of orfX
was amplified (809 bp, Table 2). The DNA sequences of
the Δ530 locus of 17 strains were analyzed using these
amplicons. Using the DNA sequence data, homology ana-
lysis was performed among these 17 strains (Additional
file 1: Table S2). Of the 17 non-JP2 strains, the Δ530 re-
gion consisted of 528 bp for strains Y4 and ATCC 29522
and 531 bp for the other strains (Additional file 1: Table
S2). The homologies were between 96.987 and 100%.
Therefore, the Δ530 locus was highly conserved among
non-JP2 strains. Furthermore, the homology search
revealed that the nucleotide sequences of the Δ530 locus
were specific to the non-JP2 strains (blastn, data not
shown). Therefore, we considered the Δ530 locus to be a
nucleotide marker for non-JP2 strains and designed a
qPCR primer set and hydrolysis probe specific to the non-
JP2 strains in this region (Table 1).
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Specificity and sensitivity of the JP2- and non-JP2-specific
primers
Using these primer pairs and probe, we confirmed the
primers’ specificity by checking their reactivity with
various strains of A. actinomycetemcomitans and other
oral bacteria (Tables 2 and Additional file 2: Table S1).
The JP2-specific primers specifically amplified the gen-
omic DNA of the A. actinomycetemcomitans JP2 clone
and did not react with other bacterial DNA, whereas
the non-JP2 specific primers reacted only with A. acti-
nomycetemcomitans non-JP2 clones (Tables 2 and
Additional file 2: Table S1). The sensitivity of this
Figure 1 Comparison of (A) the genetic organization of JP2 clones and non-JP2 strains and (B) the nucleotide sequences of the glyA gene
and orfX (orfX')-lktC locus of the JP2 strain. (A) The Δ530-bp deletion of the JP2 strain was identified. F1 and R1, Aa orfX3'F1 and Aa lktC5'R1; F2
and R2, Aa orfX3'F2 and Aa lktC5'R2. (B) The nucleotide sequence of the JP2-specific primer–probe set. The arrow indicates the Δ530-bp deletion. The
double underlined amino acid sequence (IVVWLSYSK) overlaps the 3' locus of orfX.
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TaqMan assay for A. actinomycetemcomitans JP2 and
non-JP2 clones was evaluated. Serially diluted chromo-
somal DNA of A. actinomycetemcomitans JP2 and
non-JP2 clones was used to evaluate the lower detec-
tion limits. The lower detection limit was 2.19 pg/
mixture for the JP2 clone and 2.24 pg/mixture for the
non-JP2 clone. The standard curves for linear regres-
sions between the threshold cycle (Ct) values and cor-
responding colony forming units (CFU) were obtained.
The standard curves for A. actinomycetemcomitans JP2
and non-JP2 were Y = -3.548X + 40.96, R2 = 1.00 and
Y = −3.501X + 36.91, R2 = 1.00 (Y = Ct, X = CFU),
respectively (data not shown). The detection limits of
the assays determined with serial dilutions of A. acti-
nomycetemcomitans JP2 and Y4 genomic DNA were 4
to 4 × 106 copies (for JP2, corresponding to 4 to 4 ×
106 CFU) and 11 to 1.1 × 107 copies (for Y4, corre-
sponding to 11 to 1.1 × 107 CFU), respectively (data
not shown).
Inhibitory effect of oral specimens on the assay
(spike analysis)
The presence of inhibitors in the oral specimens was
assessed using lysates spiked with dental plaque (ca. 1 g
[wet weight] per mixture, to mimic subgingival plaque)
without the A. actinomycetemcomitans JP2 clone. The
presence of dental plaque caused negligible inhibition of
the real-time PCR amplification (data not shown). A
similar spike experiment was performed using the
non-JP2 specific primers and dental plaque without A.
actinomycetemcomitans strains. Dental plaque had no
inhibitory effects on the assay (data not shown).
Quantification of the JP2 and non-JP2 clones from
subgingival plaque samples
Samples from the 88 periodontal sites (31 incisors, 44
first molars, 13 premolars) in the 11 patients with ag-
gressive periodontitis were analyzed. Nine of the 11
patients were positive for JP2 clones, and three of these
nine were also positive for non-JP2 clones. Two patients
were negative for both clones. Forty-six sites were posi-
tive for JP2 clones (52.3%); of these, nine sites were posi-
tive for both JP2 and non-JP2 clones (10.2%). One site
was positive only for non-JP2 clones (1.1%). Neither
clone was detected at 39 sites (44.3%). The bacterial cell
numbers in 88 periodontal sites ranged from 0 to 4.8 ×
108 (mean 1.28 × 107) for JP2 clones and from 0 to 1.6 ×
106 for non-JP2 clones (mean 1.84 × 105).
Correlation between periodontal status and the number
of JP2 cells
All samples were divided into two groups based on the
CAL, and the mean number of JP2 clone cells was deter-
mined. There was a significant difference in the number
between groups with CAL ≤ 6 mm (mean 4.74 mm) and
that with CAL ≥7 mm (mean 9.12 mm) (p < 0.01,
Table 3). The analysis of non-JP2 was not clear due to
the small number of non-JP2 positive samples (n = 10,
data not shown).
Discussion
Studies have shown that highly leukotoxic A. actinomy-
cetemcomitans strains, i.e., the JP2 clone, are associated
with aggressive periodontitis [8]. A cross-sectional study
of Moroccan adolescents found a strong association
Table 1 Oligonucleotide primers and hydrolysis probes used in this study
Primers or Probes Sequence Gene Size
Primer
JP2-F3 5’-TCT ATG AAT ACT GGA AAC TTG TTC AGA AT-3’ orfX’ 151 bpd
JP2-R2 5’-GAA TAA GAT AAC CAA ACC ACA ATA TCC-3’ orfX’
Non-JP2F 5’-CGC AAG TGC CAT AGT TAT CCA CT-3’ orfX (Δ530 region) 145 bpe
Non-JP2R 5’-TCG TCT GCG TAA TAA GCA AGA GAG-3’ orfX (Δ530 region)
Aa orfX3’F1 5’-AAA TCG TTG GCA TTC TCG -3’ orfX 723 bpe
Aa lktC5’R1 5’-CAA AGG AGA ATT TGC CCA -3’ lktC
Aa orfX3’F2 5’-CCG TTT TAT TCA GTT CCC -3’ orfX 809 bpe
Aa lktC5’R2 5’-TGC CCA TAA CCA AGC CAC -3’ lktC
Hydrolysis probesa, b, c
JP2 5’-FAM-ACA AAT CGT TGG CAT TCT CGG CGA A-TAMRA-3’ orfX’
Non-JP2 5’-FAM-ATA TTG TAG ACA TCG CCC-MGB-3’ orfX (Δ530 region)
aFAM, 6-carboxyfluorescein.
bTAMRA, 6-carboxytetramethylrhodamine.
cMGB, minor groove binder.
dcalculated in JP2 strain.
ecalculated in Y4 strain.
Yoshida et al. BMC Infectious Diseases 2012, 12:253 Page 4 of 10
http://www.biomedcentral.com/1471-2334/12/253
between the presence of the JP2 clone and periodontal
attachment loss [23]. Furthermore, a population-based
longitudinal study found an increased risk of developing
periodontal attachment loss when the JP2 clone of A.
actinomycetemcomitans was present in the subgingival
plaque [8,30]. However, these investigations were based
on qualitative evaluations of the JP2 strain, i.e., the rela-
tionship between the presence or absence of JP2 and the
severity of aggressive periodontitis. The quantitative
relationship between the number of JP2 cells and the se-
verity of aggressive periodontitis had not been discussed
prior to this report. A previous investigation reported a
differentiation and quantification method for A. actino-
mycetemcomitans JP2 and 652 strains [26]. However, this
differentiation system was based on amplicon size differ-
ences and requires agarose gel electrophoresis or
melting-curve analysis to distinguish these strains.
Therefore, the assay is not a primer-specificity-based
method. Consequently, we developed both JP2-clone-
Table 2 Primer specificity for the Aggregatibacter actinomycetemcomitans strains





ATCC 29523 a non-JP2 - + 1 ATCCc
SUNYaB 75 (ATCC 43717) a non-JP2 - + 1 SUNYaBd
TN-1 a non-JP2 - + 2 Nishiharae
Y4 (ATCC 43718) b non-JP2 - + 1 Socranskyf
JP2 (HK921) b JP2 + - - Kiliang
HK 1199 b JP2 + - - Kilian
HK 1519 b JP2 + - - Kilian
HK 1611 b JP2 + - - Kilian
HK 1612 b JP2 + - - Kilian
HK 1651 b JP2 + - - Kilian
HK 1709 b non-JP2 - + 1 Kilian
ATCC 29522 b non-JP2 - + 2 ATCC
ATCC 29524 b non-JP2 - + 1 ATCC
HK 916 c non-JP2 - + 1 Kilian
SUNYaB 67 (ATCC 43719) c non-JP2 - + 1 SUNYaB
NCTC 9709 c non-JP2 - + 2 NCTCh
NCTC 9710 c non-JP2 - + none NCTC
3381 d non-JP2 - + 2 Asikaineni
IDH 781 d non-JP2 - + 2 Asikainen
OMZ 534 e non-JP2 - + 2 Gmürj
OMZ 541 e non-JP2 - + 2 Gmür
OMZ 546 e non-JP2 - + 2 Gmür
NUM 5005 f non-JP2 - + 2 Takadak
NUM 4039 g non-JP2 - + 2 Takada
a +, positive amplification with a band of the expected size; -, no amplification observed.
b1, Aa orfX3’F1 and Aa lktC5’R1; 2, Aa orfX3’F2 and Aa lktC5’R2 (Table 1); none, not 1 or 2s.
cATCC, American Type Culture Collection, Rockville, Md.
dSUNYaB, State University of New York at Buffalo, NY.
eNishihara, T. Nishihara, Kyushu Dental College, Kitakyushu, Japan.
fSocransky, S. Socransky, Forsyth Dental Center, Mass.
gKilian, M. Kilian, University of Aarhus, Aarhus, Denmark.
hNCTC, National Collection of Type Cultures, London, England.
iAsikainen, S. Asikainen, University of Helsinki, Helsinki, Finland.
jGmür, R. Gmür, University of Zurich, Zurich, Switzerland.
kTakada, K. Takada, Nihon University School of Dentisry at Matsudo, Chiba, Japan.
Table 3 The number of JP2 clones in 88 subgingival
plaque samples and the grouping in terms of the CAL
CAL Mean ± SD of bacterial cell number Pa
≤ 6 mm (n= 31) 3.79×105 ± 1.58×105 0.003
≥ 7 mm (n= 57) 1.92×107 ± 8.35×107
a Mann–Whitney test.
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and non-JP2-clone-specific quantification methods based
on primer specificity and the qPCR technique.
First, we analyzed the nucleotide sequences of the pro-
moter region of the ltxC/lktC gene. For this purpose, we
analyzed the PCR products using the primer pairs Aa
orfX3'F1 and Aa lktC5'R1 or Aa orfX3'F2 and Aa
lktC5'R2. However, the orfX-ltxC/lktC locus was not
amplified only in the NCTC 9710 strain using these pri-
mers. In addition, using the primer pair Aa orf3’F1-Aa
lktC5’R2 and Aa orf3’F2-Aa lktC5’R1, the orfX-ltxC/lktC
locus in the NCTC 9710 strain was not amplified by
PCR. We postulated that the DNA sequences of these
primers differ from those of the NCTC 9710 strain, but
this is no more than a supposition. As described previ-
ously, the most dramatic variation is an approximately
530-bp deletion in the JP2 leukotoxin promoter relative
to the non-JP2 strain [17,18,20]. The 530-bp deletion
removes a DNA segment starting in the middle of orfX,
a 762-bp ORF found in Y4 and ATCC 33384, and con-
tinues to a position 25 bp 5' to the ltxC/lktC start codon.
Additionally, IGR1851 was identified between the glyA
and ltxC/lktC genes. According to the Oralgen database
(http://www.oralgen.lanl.gov/_index.html) of the Los
Alamos National Laboratory, the nucleotide sequence of
IGR1851 of HK1651 is on the strand opposite that of Y4
and JP2 (Figure 1A). Consequently, we designed a sense
primer and hydrolysis probe inside orfX' and the anti-
sense primer border of the 3' region of orfX' and 3' of
orfX (Figure 1B, double underlined). For the JP2 clone,
the sense and antisense JP2-specific primers anneal to
the appropriate loci on orfX' (Figure 2). For the non-JP2
clone, however, the sense primer anneals to orfX', while
the antisense primer is not able to anneal to the 3'
border of orfX' due to the lack of 530-bp deletion
(Figure 2). This primer design successfully amplified only
the JP2 clone. Conversely, non-JP2 specific oligonucleo-
tide primers were designed inside the Δ530-bp locus. To
analyze the conservation and specificity of the Δ530-bp
locus, we sequenced it, revealing that the Δ530-bp locus
is highly conserved among non-JP2 strains (ranging from
96.987 to 100%). The non-JP2-specific primer sets suc-
cessfully amplified non-JP2 strains, but not the JP2 strain.
As shown in Table 2, the specificities of these assays were
evaluated. Additionally, we examined the effect of non-
target DNA on this assay, and the influence of the co-
presence of non-target DNA was negligible (data not
shown). This spiking experiment showed that this char-
acteristic is suited to detection in oral specimens. Next,
we evaluated the sensitivities of this assay. Using serially
diluted chromosomal DNA (see results), we found that
the sensitivities of these assays were consistent with pre-
vious studies [27,31]. Using this assay, we detected and
quantified both JP2 and non-JP2 clones from subgingival
plaque samples from adolescents.
In this study, 48 (54.5%) of the 88 periodontal sites (in
nine of 11 individuals) were positive for JP2 clones. Pre-
vious studies reported that the prevalence of the JP2
strain in Moroccan adolescents was 50 of 428 (11.7%)
individuals [8] and 43 of 365 (11.8%) individuals [30].
Our study subjects were aggressive periodontitis patients,
whereas the other studies included subjects with healthy
periodontium. Therefore, those data cannot strictly be
compared with our results. Additionally, the JP2 and
non-JP2 clones were detected using conventional PCR in
those studies. Seki et al. applied the loop-mediated iso-
thermal amplification (LAMP) method for detecting the
JP2 clone in subgingival plaque from Moroccan adoles-
cents and found that 48 of 72 samples (66.7%) were JP2
positive [25]. The LAMP technology was very sensitive
for the JP2 clone, and the detection limit was 10 genome
copies, whereas that with conventional PCR was 100 cop-
ies [25,32,33]. These findings are identical to the sensitiv-
ity of qPCR, and the detection rate was similar to our
result (54.5%). In this study, we quantified the number of
cells of the JP2 and non-JP2 clones. We also analyzed the
relationship between cell number and CAL. There was a
significant difference in JP2 cell number between group
with a CAL ≤6 mm and that with ≥7 mm (p < 0.01). The
mean JP2 cell number of the CAL >7 mm group was
more than 50 times that of the CAL <6 mm group. Previ-
ously, several population-based studies demonstrated that
Figure 2 Designation of the oligonucleotide primers and
probes specific to the JP2 clone (above) and non-JP2 strains
(below). For the JP2-specific amplification, the sense primer and
hydrolysis probe are complementary to orfX' (for JP2 clone) and orfX
(for non-JP2 strains). The antisense primer was designed to be
complementary to the border of the 3' end of orfX' for the specific
amplification of JP2 clones. For non-JP2-specific selection, the sense
and antisense primers and TaqMan probe were designed to be
complementary to the orfX Δ530 region.
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the presence of the A. actinomycetemcomitans JP2 clone
increased the risk of progression of CAL over a 2-year
period [8,22]. However, those were qualitative studies
using conventional PCR. We showed that the number of
JP2 cells was associated with the severity of aggressive
periodontitis, making our study the first to reveal a quan-
titative relationship between the JP2 strain and CAL in
aggressive periodontitis. This strongly supports the find-
ings that the A. actinomycetemcomitans JP2 clone is an
agent in the etiology of aggressive periodontitis. However,
the quantitative analysis of aggressive periodontitis has
just started, and further molecular-based epidemiological
studies are required.
Finally, combined with population-based studies, our
investigation will contribute to elucidating the quantita-
tive relationship between the number of A. actinomyce-
temcomitans JP2 clones and the severity of aggressive
periodontitis. These fundamental data will allow risk as-
sessment to determine prevention and treatment strat-
egies for this disease.
Conclusions
We present the first method for the quantitative detec-
tion of A. actinomycetemcomitans JP2 and non-JP2
clones. The technique is based on real-time PCR meth-
odology with TaqMan probe and primers specifically
designed to discriminate these clones. This method was
used to quantify A. actinomycetemcomitans JP2 in the
periodontal pockets of patients with aggressive peri-
odontitis, and revealed a significant difference in the
number of A. actinomycetemcomitans JP2 cells between
subjects with CALs ≤6 mm and those with CALs ≥7
mm (p < 0.01). This technique will contribute to future
investigations of the quantitative relationship between A.
actinomycetemcomitans and aggressive periodontitis.
Methods
Bacterial strains and culture conditions
The A. actinomycetemcomitans strains listed in Table 2
were grown in Trypticase soy broth (Becton Dickinson,
Sparks, MD) supplemented with 0.6% yeast extract (Becton
Dickinson) and 0.04% sodium bicarbonate at 37°C in a 5%
CO2 atmosphere [34]. Other oral bacteria used in this study
are listed as supplemental data (Additional file 2: Table S1).
DNA techniques
Routine molecular biology techniques were performed
as described by Sambrook et al. [35]. Chromosomal
DNA was isolated from the bacteria listed in Tables 2
and Additional file 2: Table S1 using a Puregene DNA
isolation kit (Gentra Systems, Minneapolis, MN). Nu-
cleotide sequence information for A. actinomycetemco-
mitans HK1651 was obtained from the Oral Pathogen
Sequence Database (Los Alamos National Laboratory,
http://www.oralgen.lanl.gov/).
DNA sequencing of the Δ530 region of orfX
The genetic structures of the JP2 clone and non-JP2
strain are shown in Figure 1A. To design highly specific
oligonucleotide primers for real-time PCR-based detec-
tion of A. actinomycetemcomitans non-JP2 strains, the
Δ530 region of orfX was sequenced using two oligo-
nucleotide primer pairs (Table 1). Initially, Aa orfX3'F1
(137–154 bp from the 5’ end of orfX) and Aa lktC5'R1
(49–66 bp from the 5’ end of lktC) were used for all
strains, and Aa orfX3'F2 (33–50 bp from the 5’ end of
orfX) and Aa lktC5'R2 (37–54 bp from the 5’ end of
lktC) were used for Aa orfX3'F1- and Aa lktC5'R1-
negative strains (Table 2). The PCR conditions consisted
of 95°C for 5 min, followed by 25 cycles of 95°C for 30 s,
47°C for 30 s, and 72°C for 1 min for primers Aa
orfX3'F1 and Aa lktC5'R1 and 95°C for 5 min, followed
by 25 cycles of 95°C for 30 s, 49°C for 30 s, and 72°C for
1 min for primers Aa orfX3'F2 and Aa lktC5'R2. DNA
sequencing of these PCR amplicons, performed using an
Applied Biosystems 3730 DNA Analyzer (Applied Bio-
systems, Foster City, CA) and BigDye Terminator v3.1
Cycle Sequence Kit (Applied Biosystems) at Hokkaido
System Science (Hokkaido, Japan), yielded a consensus
sequence and allowed us to design non-JP2 strain-
specific primers (Table 1).
Primers and probe design
A hydrolysis probe-based qPCR assay (TaqMan assay) was
used for the specific detection of A. actinomycetemcomitans
JP2 and non-JP2 strains. The oligonucleotide primers and
hydrolysis probe were designed from the orfX' region and its
3' border sequences (for JP2 clones; Oral Pathogen Sequence
Database number: AA02808) and Δ530 region of orfX (for
non-JP2 strains) using Primer Express 3.0 (Applied Biosys-
tems). As shown in Table 1, the hydrolysis probe specific for
the JP2 clone was labeled with 6-carboxyfluorescein (FAM)
and 6-carboxytetramethylrhodamine (TAMRA) and for the
non-JP2 clone the hydrolysis probe was labeled with FAM
and minor groove binder (MGB). The primer specificity was
initially confirmed by gapped blastn 2.0.5 (National Center
for Biotechnology Information, http://www.ncbi.nlm.nih.gov/)
analysis and then by conventional PCR performed using
chromosomal DNA from various oral bacteria (Table 2
and Additional file 2: Table S1). These PCR assays were
performed using thermocycler conditions of 94°C for 5
min, followed by 25 cycles of 94°C for 30 s, 60°C for 30 s,
and 72°C for 1 min for the JP2 clone and 94°C for 5 min,
followed by 25 cycles of 94°C for 30 s, 49°C for 30 s, and
72°C for 1 min for non-JP2 clones.
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qPCR
Chromosomal DNA from bacterial cultures and clinical
specimens and a negative control sample were amplified
using LightCycler TaqMan Master (Roche Diagnostics
GmbH, Mannheim, Germany). The amplification reac-
tion mixture consisted of DNA template, 5× Master
Mix, forward and reverse primers (0.5 μM each), 0.2 μM
hydrolysis probe, and PCR-grade water in a LightCycler
Capillary (Roche Diagnostics). Specific products were
amplified and detected using the LightCycler Carousel-
based System (Roche Diagnostics), with the following
thermal conditions: 95°C for 10 min, followed by 45
cycles of 95°C for 10 s, 58°C for 40 s, and 72°C for 1 s
for both JP2 and non-JP2 strains. The endpoint amplifi-
cation products were further separated on 2% agarose
gels to confirm that they were of the predicted sizes.
Study subjects
Eleven adolescents and young adults 16–31 years old
(three males, eight females; mean ± SD age 26.6 ± 4.1
years), diagnosed with aggressive periodontitis at the Den-
tal Hospital, Université Mohammed V Souissi in Rabat,
Morocco, participated in this study. Subjects were
excluded if they used antibiotics within the preceding year,
were undergoing ongoing periodontal treatment (scaling,
root planing, and professional tooth cleaning), had ortho-
dontic or prosthetic devices, had used mouth rinse rou-
tinely in the previous 6 months, or were smokers.
Ethics statement
All patients were treated in accordance with the Declar-
ation of Helsinki on the participation of human subjects
in medical research. Ethics clearance for the study was
obtained from Comité d’Ethique pour la Recherché Bio-
médicale (CERB), Université Mohammed V Souissi
(reference number 400). Patients were fully informed
and signed informed consent forms.
Clinical examination
The clinical attachment level (CAL) in the periodontium
was measured as the distance in millimeters from the
cement-enamel junction to the bottom of the periodon-
tal pocket using a periodontal probe at eight sites (i.e.,
the buccal aspects of the mesial surfaces of the upper
and lower first incisors and the first molars; if a tooth
was missing, the premolar on the same side was used),
for a total of 88 sites. To determine the reproducibility
of the CAL recordings, all subjects were examined twice
at a 2-week interval using identical procedures. The
same examiner (O.-K.E.) performed both examinations,
but was not aware of the initial findings at the time of
the second examination. The reproducibility of record-
ing the CAL was evaluated by measuring the kappa
value, which was 0.65.
Microbiological sampling and preparation
Subgingival samples on paper points were obtained from
the adolescents, as described previously [8]. Briefly, sub-
gingival plaque samples were obtained by inserting a
sterile paper point into a subgingival site for 10 s. The
paper point was transferred into 200 μl of phosphate-
buffered saline (PBS) and centrifuged at 12,000 × g for 5
min. After centrifugation, the bacteria chromosomal
DNA was extracted using MORA-extract (Cosmo Bio,
Tokyo, Japan), according to the manufacturer’s instruc-
tions, and then served as a template. After centrifuga-
tion, the supernatant was removed, and 150 μl of lysis
buffer were added to the pellet. The lysed bacteria were
transferred to a tube with glass beads and heated at 90°C
for 10 min. Then, the bacterial mixture was disrupted
using a Mini-Bead Beater (Biospec Products, Bartlesville,
OK) with 0.1-mm-diameter glass beads at 4,800 rpm for
2 min. After this procedure, 200 μl of SDS solution were
added and heated at 90°C for 10 min. Then, 400 μl of
phenol solution were added and mixed for 1 min. After
centrifugation, the aliquot was subjected to ethanol pre-
cipitation and dissolved in 20 μl of TE buffer.
Statistical analysis
Intergroup bacterial cell numbers were analyzed using the
Mann–Whitney test. The kappa value was measured to
determine the reproducibility of recording the CAL. Stat-
istical analysis was performed with the program SPSS 11.0
(SPSS, Chicago, IL), and the differences were considered
significant when the p-value was less than 0.05.
Additional files
Additional file 1: Table S2. Homology analysis of the = ==530 region of
A. actinomycetemcomitans non-JP2 strains.
Additional file 2: Table S1. Bacterial strains other than Aggregatibacter
actinomycetemcomitans used for primer-specificity analysis.
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